Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Data is from peer reviewed journal

Data source

Reference
Reference Type:
publication
Title:
Chemical models for toxic metabolites of bromobenzene derivatives: Relative toxicity toward isolated hepatocytes.
Author:
DAVID W. G (YrTSCHALL, RAYMOND R. HARDER~,ROBERT A. WILEY and ROBERT P. HANZLIK
Year:
1984
Bibliographic source:
TOXICOLOGY; 31 (3-4). 1984. 251-260.

Materials and methods

Objective of study:
metabolism
Test guideline
Qualifier:
according to guideline
Guideline:
other: refer below principle
Principles of method if other than guideline:
In Vitro metabolism of Cyclohexenecarbonitrile by using Sprague-Dawley rats cell line
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Cyclohexenecarbonitrile
EC Number:
217-454-2
EC Name:
Cyclohexenecarbonitrile
Cas Number:
1855-63-6
IUPAC Name:
cyclohex-1-ene-1-carbonitrile
Test material form:
other: Liquid
Details on test material:
- Name of test material (as cited in study report):Cyclohexenecarbonitrile- Molecular formula (if other than submission substance):C7H9N- Molecular weight (if other than submission substance):107.155- Smiles notation (if other than submission substance):N#CC1=CCCCC1- InChl (if other than submission substance):1S/C7H9N/c8-6-7-4-2-1-3-5-7/h4H,1-3,5H2- Substance type:Organic- Physical state:Liquid
Radiolabelling:
not specified

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
not specified

Administration / exposure

Route of administration:
other: Incubation
Vehicle:
other: 20 μl pentane
Details on exposure:
For lower concentrations of the more volatilecompounds (i.e. ≤ 5 mM; compounds Cyclohexenecarbonitrile) the incubation flask was charged with cells, flushed with O2/CO2 mixture, and the appropriate amount of test compound dissolved in 20 μl pentane was applied to a moist piece of filter paper (1 × 3 cm) adhering inside the neck of the flask just prior to capping the flask.
Duration and frequency of treatment / exposure:
Once
Doses / concentrations
Remarks:
Doses / Concentrations:2-4 mM
No. of animals per sex per dose / concentration:
92-95% of cells
Control animals:
not specified
Statistics:
No data

Results and discussion

Main ADME results
Type:
metabolism
Results:
Cyclohexenecarbonitrile shows lower oder of toxicity to hepatecytes were observed.

Toxicokinetic / pharmacokinetic studies

Details on absorption:
No data available
Details on distribution in tissues:
No data available
Details on excretion:
No data available

Metabolite characterisation studies

Metabolites identified:
no
Details on metabolites:
No data available

Any other information on results incl. tables

EFFECTS OF UNSATURATED COMPOUNDS AND EPOXIDES ON RELEASE OF GPT FROM ISOLATED HEPATOCYTES

Compound

Method ofaddition

Concentration studied (mM)

ECs0 (mM) for GPT release (2 h)

1

A

2

12

aContained 40-50% benzonitrile impurity

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): low bioaccumulation potential based on study resultsCyclohexenecarbonitrile expected to have Low bio-accumulation potential based on study results.
Executive summary:

In a in vivo metabolism study,Sprague-Dawley rats cell line were treated withCyclohexenecarbonitriledissolved in a 20 μl pentane was applied to a moist piece of filter paper (1 × 3 cm) adhering inside the neck of the flask just prior to capping the flask.. Cyclohexenecarbonitrileappears toshows loweer oder of toxicity to hepatecytes by low GPT release with half-maximal release of GPT within 2 h as 12 mM as compared to bromobenzene which show 2.4 mM. Which is much lower than Cyclohexenecarbonitrile. Hance, it is clear that neither the presence of a simple Michael acceptor function (Cyclohexenecarbonitrile) nor the presence of a simple epoxide moiety is sufficient to render the molecule a potent toxin.Therefore,Cyclohexenecarbonitrile considered to haveLow bio-accumulation potential based on study results.